ARCHIVES

FDA Oncology Division Invites Advocates To Play Early Role In Cancer Drug Review.

This article is from The Cancer Letter archive.

Vol. 27 No. 12 | March 23, 2001

Download PDF Visit The Full Archive

Related Articles

CCOP Reviewers Briefed On Program Objective, Criteria

January 7, 1983

NCAB Approves New Nutrition Task Force With Earmarked Funds

May 28, 1982

Evidence “Weak” Linking EMFs, cancer

June 25, 1999

Survey Finds 70 Percent of Oncologists Prescribe Avastin Off-Label For Ovarian Cancer

August 30, 2013

Linda Weiss, director of NCI Office of Cancer Centers, to Retire in March 2015

November 26, 2014

NCI’s $65 Million to NTP Will Be Controversial, Untouchable; Spectre Of Another Backlog Looms

February 8, 1980